Parecoxib Sodium API

Parecoxib Sodium API

Parecoxib Sodium API

Min.Order / FOB Price:Get Latest Price

1 Kilogram

Negotiable

  • Min.Order :1 Kilogram
  • Purity: 99%
  • Payment Terms : T/T

Keywords

Parecoxib Parecoxib API 99% Parecoxib API

Quick Details

  • Appearance:white powder
  • Application:pharmaceutical R&D
  • PackAge:drum or as required
  • ProductionCapacity:100|Kilogram|Month
  • Storage:room temperature
  • Transportation:Normal temperature transportation

Superiority:

GMP certification

could be used for finished formulation R&D and manufacture 

technical package is available for long-term cooperation 

could meet the order from lab use to commercial manufacture 

competitive price will be provided based on the quantity 

 

Bocimed does not sell compounds in the period of patent protection. According to the relevant provisions of the patent law, "the act of importing, manufacturing and using patented drugs by others before the expiration of drug patents without the consent of the patentee in order to obtain the data and other information required by the drug administration department shall be not regarded as infringing the patent right".

Details:

product name: Parecoxib Sodium API

CAS 198470-85-8

purity ≥ 99%

 

Bocimed is a technology enterprise specializing in pharmaceutical research, which was established in Zhangjiang Pharmaceutical Valley of Shanghai in 2012. Bocimed has Zhangjiang R & D headquarter, Lingang production base and Chengdu clinical subsidiary. With the unique platform advantages of solubilization technology, sustained-release technology and nanotechnology, the company is committed to become a leading enterprise in the development and production of innovative and special preparations, and realize the vision of bringing better drugs to the world.

Bocimed does not sell compounds in the period of patent protection. According to the relevant provisions of the patent law, "the act of importing, manufacturing and using patented drugs by others before the expiration of drug patents without the consent of the patentee in order to obtain the data and other information required by the drug administration department shall be not regarded as infringing the patent right".

 

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View